CNS Pharmaceuticals, Inc. fell 12.2% on Monday, November 2, 2026, on 15,100 shares. No headline about CNSP came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
CNS Pharmaceuticals, Inc. (CNSP:NASDAQ) closed at $3.92 on November 6, 2026, down 4.62% on the day. The stock trades 62.8% below its 52-week high of $10.54 and 106.3% above its 52-week low of $1.90. Over the past year, it lost 40.3%. CNS Pharmaceuticals, Inc. is part of the Health Care sector.
In 252 trading sessions since November 6, 2025, CNSP closed higher on 104 days (41%). Its best day was May 4, 2026 (+239.25%) and its worst was March 13, 2026 (-14.08%). The stock moved 10% or more in a single session 14 times. It opened at least 5% above the previous day's high 4 times.
CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma.
Find more stocks like CNSP with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.